COSMOS Pharmaceutical Corporation (3349)

Name: COSMOS Pharmaceutical Corporation (3349) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-30

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products.

Cifras clave

Capitalización bursátil: JPY 488 billion
Ingresos (ejercicio cerrado en 2026-05-31): JPY 1.10T
Beneficio neto: JPY 32.0B
Margen bruto: 20.9%
Margen neto: 2.9%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Ingresos totales	JPY 1.10T	JPY 1.01T	JPY 965.0B	JPY 827.7B	—
Beneficio bruto	JPY 229.7B	JPY 213.3B	JPY 188.3B	JPY 168.7B	—
Ingresos operativos (EBIT)	JPY 42.4B	JPY 40.4B	JPY 31.5B	JPY 30.1B	—
Ingresos netos	JPY 32.0B	JPY 31.0B	JPY 24.5B	JPY 23.8B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 3349. /companies/us/3349

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.